🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 23 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/09/2003 | 50,65 | 50,71 | 49,80 | 49,90 | -1,49% | 1,79% | 7.129.649 |
| 18/09/2003 | 50,63 | 51,22 | 50,51 | 50,65 | -0,24% | 1,41% | 5.662.554 |
| 17/09/2003 | 51,31 | 51,34 | 50,58 | 50,77 | -1,08% | 1,47% | 4.564.669 |
| 16/09/2003 | 50,91 | 51,39 | 50,57 | 51,33 | +1,32% | 1,61% | 4.818.599 |
| 15/09/2003 | 51,04 | 51,08 | 50,66 | 50,66 | -0,77% | 0,82% | 4.000.845 |
| 12/09/2003 | 51,03 | 51,13 | 49,65 | 51,05 | +0,38% | 2,90% | 4.506.714 |
| 11/09/2003 | 51,43 | 51,52 | 50,86 | 50,86 | -0,74% | 1,28% | 5.138.763 |
| 10/09/2003 | 50,56 | 51,81 | 50,52 | 51,24 | +1,72% | 2,55% | 8.777.000 |
| 09/09/2003 | 49,94 | 50,97 | 49,94 | 50,37 | +0,36% | 2,06% | 7.906.636 |
| 08/09/2003 | 49,48 | 50,46 | 49,41 | 50,19 | +3,14% | 2,12% | 9.027.786 |
| 05/09/2003 | 48,29 | 49,15 | 48,10 | 48,66 | +0,79% | 2,17% | 6.275.319 |
| 04/09/2003 | 48,37 | 48,62 | 47,98 | 48,28 | -0,16% | 1,32% | 5.905.270 |
| 03/09/2003 | 48,62 | 48,65 | 47,90 | 48,36 | -0,76% | 1,55% | 7.321.223 |
| 02/09/2003 | 47,85 | 48,89 | 47,85 | 48,73 | +1,49% | 2,17% | 7.970.669 |
| 29/08/2003 | 47,66 | 48,06 | 47,52 | 48,02 | +1,13% | 1,14% | 5.379.908 |
| 28/08/2003 | 48,01 | 48,06 | 47,21 | 47,48 | -1,07% | 1,77% | 7.064.778 |
| 27/08/2003 | 47,76 | 48,11 | 47,76 | 48,00 | +0,00% | 0,74% | 5.460.918 |
| 26/08/2003 | 48,01 | 48,18 | 47,60 | 48,00 | +0,02% | 1,21% | 6.972.763 |
| 25/08/2003 | 47,85 | 48,60 | 47,85 | 47,99 | +0,04% | 1,56% | 5.970.875 |
| 22/08/2003 | 49,05 | 49,10 | 47,85 | 47,97 | -2,05% | 2,55% | 9.283.394 |
| 21/08/2003 | 49,90 | 49,90 | 48,76 | 48,97 | -1,53% | 2,29% | 8.971.194 |
| 20/08/2003 | 48,58 | 50,01 | 48,57 | 49,73 | -2,98% | 2,97% | 10.712.551 |
| 19/08/2003 | 51,05 | 51,48 | 50,38 | 51,26 | +0,43% | 2,15% | 6.107.639 |
| 18/08/2003 | 51,10 | 51,36 | 50,95 | 51,04 | +0,02% | 0,78% | 5.235.179 |
| 15/08/2003 | 50,91 | 51,14 | 50,24 | 51,03 | +0,26% | 1,76% | 3.705.309 |
| 14/08/2003 | 50,68 | 50,95 | 50,12 | 50,90 | -0,15% | 1,64% | 6.903.490 |
| 13/08/2003 | 51,57 | 51,77 | 50,67 | 50,97 | -2,04% | 2,13% | 7.904.750 |
| 12/08/2003 | 52,50 | 52,58 | 51,60 | 52,03 | -0,93% | 1,85% | 6.142.328 |
| 11/08/2003 | 53,05 | 53,12 | 51,97 | 52,52 | -0,99% | 2,18% | 6.192.108 |
| 08/08/2003 | 53,34 | 53,44 | 52,81 | 53,04 | -0,55% | 1,20% | 4.786.426 |